APOBEC3H Activators
The APOBEC3H Activators category encompasses a range of chemical compounds that have the potential to enhance the functional activity of APOBEC3H, a critical enzyme in the innate immune response against viral infections. Antiretroviral drugs like Zidovudine, Tenofovir, and Raltegravir indirectly enhance APOBEC3H activity by creating a cellular environment where the reliance on innate immune mechanisms, including the APOBEC3H-mediated mutation of viral DNA, is increased.
Compounds like Epigallocatechin gallate and Resveratrol, known for their antiviral properties, might augment APOBEC3H's role in disrupting viral DNA integrity. The Cytidine Deaminase Inhibitor Tetrahydrouridine, while directly inhibiting a different enzyme, could indirectly promote the distinct deaminase activity of APOBEC3H. Moreover, JQ1, as a BET bromodomain inhibitor, may influence the transcriptional regulation of genes like APOBEC3H, thereby modulating its expression and activity. Leflunomide and Curcumin, known for their immunomodulatory effects, could indirectly contribute to the enhanced activity of APOBEC3H in the immune response against viral infections. This collection of compounds demonstrates the diverse potential for pharmacologically targeting the antiviral mechanisms of APOBEC3H, underscoring its significance in the innate immune defense against viral pathogens.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
3′-Azido-3′-deoxythymidine | 30516-87-1 | sc-203319 | 10 mg | $61.00 | 2 | |
A reverse transcriptase inhibitor used in HIV treatment; could enhance APOBEC3H-mediated viral resistance by increasing reliance on innate immunity. | ||||||
Tenofovir | 147127-20-6 | sc-204335 sc-204335A | 10 mg 50 mg | $157.00 $646.00 | 11 | |
Another antiretroviral drug that could enhance APOBEC3H activity by increasing the dependence on innate immune mechanisms for viral resistance. | ||||||
Tetrahydrouridine | 18771-50-1 | sc-204339 | 10 mg | $416.00 | 1 | |
While it inhibits cytidine deaminase, it may indirectly enhance the distinct activity of APOBEC3H in DNA editing. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A polyphenol with antiviral properties, potentially enhancing APOBEC3H activity in antiviral defense mechanisms. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
An antiviral drug; its action might lead to increased activation of APOBEC3H as part of an enhanced immune response to viral infection. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Has been shown to have antiviral properties, potentially enhancing APOBEC3H's role in viral DNA mutation. | ||||||
Raltegravir | 518048-05-0 | sc-364600 sc-364600A sc-364600B sc-364600C sc-364600D | 5 mg 50 mg 100 mg 500 mg 1 g | $100.00 $821.00 $1229.00 $2861.00 $4085.00 | 21 | |
An HIV integrase inhibitor, could indirectly enhance the functional role of APOBEC3H in antiviral defense. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
A BET bromodomain inhibitor, may influence the transcriptional regulation of genes including APOBEC3H. | ||||||
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $83.00 | 5 | |
An immunomodulatory drug, could enhance APOBEC3H's activity in immune response through its antiproliferative effects. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Known for its broad biological activities, may indirectly enhance APOBEC3H function in immune response and antiviral activity. | ||||||